We measure with scientific precision
Celvia is an Estonian company and research institution based on Estonian capital, with shareholders including, among others, the University of Tartu and Tartu University Hospital.
About us
Celvia’s mission is to develop and deliver innovative science-based products and services for patients, clinicians and businesses. We collaborate with researchers and clinicians from Estonia and abroad to ensure the high quality of basic research.
We combine new knowledge with state-of-the-art technology and unique skills, resulting in competitive genetic tests that meet high standards.
Celvia is an Estonian company and research institution based on Estonian capital, with shareholders including, among others, the University of Tartu and Tartu University Hospital.
Years of experience
Accomplished EU projects
Staff with PhD
Staff
Science
Services
Services
Celvia’s services comply with strict quality standards and are supervised by the Estonian Accreditation Centre and the Health Board. The activity licence issued by the Health Board is L05235.
Celvia holds an ISO 15189:2022 medical laboratory certificate (M018) in the field of genetics (NIPTIFY). The NIPTIFY and beREADY tests are covered by IVD marking. The company maintains valid patient liability insurance.
In addition, Celvia holds an ISO 17025:2017 testing laboratory certificate (L317) in the field of genetics for honey DNA metagenomic analysis (MDA v2).
Niptify
An accurate and safe test that analyses the most important fetal chromosomal diseases. Only one maternal blood sample is needed.
BeReady
A personalised medicine test for infertility treatment, which can be used as a basis for planning embryo transfer and designing a treatment plan.
InvisibleMi
A highly private test for detecting and monitoring microbial communities in the female and male genital tract.
PGT-A test
A precision medicine test for infertility treatment to select embryos with healthy chromosomes for transplantation.
Honey Metagenomic DNA Analysis (MDA)
The test gives a comprehensive picture of the composition and origin of honey and helps to detect honey adulteration.
CLARITY
An innovative non-invasive test for identifying chromosomal causes of pregnancy loss from as early as 6 weeks of gestation – requiring only a single blood sample.
Media
We cover our activities on TV, in newspapers and on the radio. You can follow us Facebook and Instagram pages.
Mission
We do our best to ensure that the best achievements of science don’t just remain on paper, but reach medicine and food safety, benefiting people every day.
"Celvia, formerly CCHT, is a very successful link between basic research and medicine. It is a pleasure to be involved in the whole process from scientific idea to genetic test."
Professor Andres Salumets, Founder and Board Member
Scientific articles
300+ articles
Our researchers have published more than 300 articles in journals in biomedicine, molecular biology, developmental biology and bioinformatics. We are equally open to research in basic and applied science, because this is how new discoveries meet healthcare and food safety industry.
